A PROSPECTIVE STUDY ON THE RISK FACTORS, TOAST CLASSIFICATION, AND MANAGEMENT OF ACUTE ISCHEMIC STROKE IN A TERTIARY CARE CENTER
DOI:
https://doi.org/10.22159/ajpcr.2025v18i11.55947Keywords:
Trial of ORG 10172 in acute stroke treatment, Acute ischemic stroke, Tissue plasminogen activatorAbstract
Objectives: Stroke contributes to being the fourth and third highest major cause of mortalities in India and in the global scenario, respectively. The Trial of ORG 10172 in acute stroke treatment (TOAST) system of classification is essential for determining the underlying cause, easier diagnosis, and improved treatment prognosis in acute ischemic stroke (AIS). This study was planned to classify the types of AIS and assess the treatment plans accordingly for overall improvement.
Methods: A prospective, observational study was conducted for a time period of 6 months. A total of 100 patients were selected for the study. Data included demographic information, medical and family history, TOAST classification, and management.
Results: The evaluation of 100 patients revealed that stroke prevalence is higher in males than females, with the predominant age group being 61–70 years. Significant association was found with hypertension, diabetes, alcoholism, and smoking. Furthermore, this study found that large artery atherosclerosis was the most common type of AIS among the patients.
Conclusion: This study highlights the importance of identifying and managing presumable risks through past medical history, classifying and treating the underlying cause and region of AIS for better prognosis.
Downloads
References
1. World Stroke Organization. Global Stroke Fact Sheet 2025; 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11786524
2. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of disease study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140- 6736(16)31678-6. Erratum in: Lancet. 2017 Jan 7;389(10064):e1. doi: 10.1016/S0140-6736(16)32606-X, PMID: 27733282, PMCID: PMC5055577
3. Sriramcharan P, Natarajan J, Raman R, Nagaraju G, Justin A, Senthil V. A review on green-synthesis of cerium oxide nanoparticles: Focus on central nervous system disorders. Int J Appl Pharm. 2022 Jul;14(4):94-102.
4. Global Burden of Disease Study 2021. Global, regional, and national burden of stroke and its risk factors, 1990-2021: A systematic analysis for the global burden of disease study 2021. Lancet Neurol. 2023;22(6):435-46.
5. Sultana MN, Qureshi SY, Fatima I, Jabeen W, Obaid M. A prospective observational study on the assessment of potential drug-drug interactions and management of post-complications in stroke patients at a tertiary care teaching hospital. Int J Pharm Pharm Sci. 2021 Nov;13(11):8-14.
6. Justyn M, Yulianti T, Wilar G. Long-term covid-19 effect to endothelial damage trough extrinsic apoptosis led to cardiovascular disease progression: An update review. Int J Appl Pharm. 2023 Nov;15(6):60-8.
7. StatPearls Publishing. Transient Ischemic Attack. In: StatPearls; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/nbk459143
8. Basaraba JE, Picard M, George-Phillips K, Mysak T. Pharmacists as care providers for stroke patients: A systematic review. Can J Neurol Sci. 2018;45(1):49-55. doi: 10.1017/cjn.2017.348
9. Johansson A, Drake I, Engström G, Acosta S. Modifiable and non-modifiable risk factors for atherothrombotic ischemic stroke among subjects in the malmö diet and cancer study. Nutrients. 2021;13(6):1952.
10. Liu Y, Zhang Y, Liu X. Modifiable and non-modifiable risk factors in ischemic stroke: A meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(6):104803. doi: 10.1016/j.jstrokecerebrovasdis.2020.104803
11. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35-41. doi: 10.1161/01.str.24.1.35
12. American Heart Association/American Stroke Association. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):e344-418. doi: 10.1161/ STROKEAHA.119.027708
13. American Heart Association/American Stroke Association. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/ American Stroke Association. Stroke. 2021;52(7):e364-467. doi: 10.1161/STR.0000000000000375
14. Taha M. Therapeutic use of alpha-lipoic acid supplementation: A review on current use and future prospective. Int J Appl Pharm. 2024;16(6):21-7. doi: 10.22159/ijap.2024v16i6.51319
15. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58(5):688-97. doi: 10.1002/ana.20617
16. Mohammad Yaseen Abbasi M, et al. A comparison of risk factors and severity of ischemic stroke in female and male genders in North- West Iran: A cross-sectional study. Iran J Neurol. 2018;13(4):215-9. doi: 10.18502/ijnl.v13i4.1325
17. Soto-Cámara R, González-Bernal JJ, González-Santos J, Aguilar- Parra JM, Trigueros R, López-Liria R. Age-related risk factors at the first stroke event. J Clin Med. 2020;9(7):2233. doi: 10.3390/jcm9072233
18. Monjezi S, et al. Prevalence of risk factors in ischemic stroke patients: A cross-sectional study. J Stroke Cerebrovasc Dis. 2019;28(12):104383. doi: 10.1016/j.jstrokecerebrovasdis.2019.104383
19. Adams HP, Biller J. Classification of subtypes of ischemic stroke: History of the trial of org 10172 in acute stroke treatment classification. Stroke. 2015;46:e114-7. doi: 10.1161/strokeaha.115.010694
20. Majumder D. Ischemic stroke: Pathophysiology and evolving treatment approaches. Neurosci Insights. 2024;19:26331055241292600. doi: 10.1177/26331055241292600
Published
How to Cite
Issue
Section
Copyright (c) 2025 Pragathi Reddy Gunnam, PAVAN RAJ GOUD GUGGILLA, SAI SHARANYA MANDALA, DR. SHAILESH MOHAN BADOLE, MOHAMMED SALMAN AHMED
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
